Related Experiment Video
Updated: Sep 3, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Low-dose statins improve prognosis of patients with ischaemic stroke undergoing intra-arterial thrombectomy: A
Chaohua Cui1, Shuju Dong2, Qian Liu2
1Department of Rehabilitation, Liuzhou Municipal Liutie Central Hospital, Liunan Distract, Liuzhou, Guangxi, China.
Insights
Low-dose statins improve outcomes for Asian patients undergoing thrombectomy for acute ischemic stroke. This treatment is linked to better neurological function, functional recovery, and reduced mortality, with no increase in bleeding risk.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- High-dose statins are recommended for stroke patients undergoing thrombectomy.
- Low-dose statins are effective in Asian populations but their role in thrombectomy patients is unclear.
- The study investigates the impact of low-dose statins on prognosis and bleeding risk in this patient group.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose statin use in Asian patients with acute ischemic stroke undergoing intra-arterial thrombectomy.
- To determine the association between low-dose statins and neurological improvement, functional outcomes, and mortality.
- To assess the effect of low-dose statins on in-hospital hemorrhage events.
Main Methods:
- Prospective data collection from patients undergoing intra-arterial thrombectomy for acute ischemic stroke.
- Efficacy outcomes included National Institutes of Health Stroke Scale (NIHSS) score improvement at 7 days and favorable functional outcome (FFO) at 90 days.
- Safety outcomes assessed in-hospital hemorrhage rates and 2-year mortality.
Main Results:
- 256 patients were included in the study.
- The low-dose statin group showed higher NIHSS improvement, higher FFO rates, and lower mortality compared to the control group.
- Low-dose statin use was significantly associated with improved NIHSS scores (OR=1.773), FFO (OR=2.962), and reduced mortality (OR=0.554). A lower percentage of gastrointestinal hemorrhage was observed in the statin group.
Conclusions:
- Low-dose statin use is significantly associated with improved neurological function at 7 days post-thrombectomy in Asian patients.
- Low-dose statins are linked to better functional outcomes at 90 days and reduced mortality within 2 years.
- The findings suggest low-dose statins are beneficial for Asian acute ischemic stroke patients undergoing thrombectomy, without increasing bleeding risk.
Background:
High-dose statins are recommended as preventive drugs in guidelines for patients with ischaemic stroke undergoing thrombectomy. Not only in clinical practice but also based on large-scale studies, low-dose statins have been widely used and demonstrated to be efficient in Asian populations. However, it remains unknown whether a low-dose statin is related to the prognosis of patients with thrombectomy. Can low-dose statins reduce the risk of bleeding at the same time?
Methods:
We prospectively collected data from patients with acute ischaemic stroke undergoing intra-arterial thrombectomy. Efficacy outcomes were National Institutes of Health Stroke Scale (NIHSS) score improvement at 7 days after admission and a favourable functional outcome (FFO) at 90 days. Safety outcomes were rates of in-hospital haemorrhage events and death within 2 years.
Results:
We included 256 patients in this study. Compared with the control group, the low-dose statin group had a higher NIHSS improvement rate at 7 days, a higher FFO rate at 90 days and a lower death rate within 2 years. The low-dose statin group had a lower percentage of gastrointestinal haemorrhage. Statin use was significantly related to an improved NIHSS score (p = 0.028, OR = 1.773) at 7 days and FFO (P < 0.001, OR = 2.962) at 90 days and to lower death rates (P = 0.025, or = 0.554) within 2 years.
Conclusion:
In Asian acute ischaemic stroke patients with intra-arterial thrombectomy, low-dose statin use was significantly related to NIHSS improvement at 7 days, FFO at 90 days and decreased death rates within 2 years.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

